MENS — Jyong Biotech Ltd. (Stock)

Price: $2.14 · 1 day: -10.08% · 5 days: +3.88% · 1 month: -3.60% · YTD: -45.82%
As of 2026-09-23 20:00 UTC.

52-week range: $1.43 – $63.0 (currently at 1% of the range).

The read

MENS is in a downtrend, momentum firm. $2.2 is the level overhead; $2 the first support below.

3 of 6 technical checks lean bearish.

Trend	Downtrend · below 50-day & below 200-day
Momentum	RSI 46.1 · neutral · MACD bullish
Trend strength	ADX 12.7 · weak or range
Location	-2.7% vs 50-day MA
52-week range	-97% from high · +47% from low
Volatility	ATR 0.21 · ~9.8%/day

Next earnings: 2026-11-12.

Jyong Biotech completes primary endpoint analysis for Phase II trial of MCS-8 — Jyong Biotech (MENS) announced that it has achieved another milestone in the development of its plant-derived new drug MCS-8, PCP. The Company has completed the statistical analysis of the primary efficacy endpoints in i (TipRanks, 2025-11-21)
Exploring Jyong Biotech’s (NasdaqGM:MENS) Valuation Following Recent Share Price Volatility — Jyong Biotech (NasdaqGM:MENS) has seen some interesting moves in recent sessions, with the stock climbing about 12% yesterday despite no headline news driving the action. Investors appear to be weighing broader sector mo (Simply Wall St., 2025-11-21)
Evaluating Jyong Biotech (NasdaqGM:MENS): What Recent Price Moves Reveal About Its Current Valuation — Jyong Biotech (NasdaqGM:MENS) is suddenly catching the eye of investors after a recent move in its share price, even without any major event driving headlines. Sometimes stocks stir up attention precisely because there i (Simply Wall St., 2025-09-14)